본문으로 건너뛰기
← 뒤로

miRNA-HK2 networks in cancer metabolism: Mechanisms and dual-targeting therapeutic opportunities.

Biochimica et biophysica acta. Reviews on cancer 2026 Vol.1881(1) p. 189530

Jiang X, Li X, Lee LTO, Tam KY

📝 환자 설명용 한 줄

Metabolic reprogramming, exemplified by the Warburg effect, is a hallmark of cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Jiang X, Li X, et al. (2026). miRNA-HK2 networks in cancer metabolism: Mechanisms and dual-targeting therapeutic opportunities.. Biochimica et biophysica acta. Reviews on cancer, 1881(1), 189530. https://doi.org/10.1016/j.bbcan.2026.189530
MLA Jiang X, et al.. "miRNA-HK2 networks in cancer metabolism: Mechanisms and dual-targeting therapeutic opportunities.." Biochimica et biophysica acta. Reviews on cancer, vol. 1881, no. 1, 2026, pp. 189530.
PMID 41506330

Abstract

Metabolic reprogramming, exemplified by the Warburg effect, is a hallmark of cancer. Hexokinase 2 (HK2), a key glycolytic enzyme, is frequently overexpressed in cancer, sustaining glucose metabolism and tumor progression. MicroRNAs (miRNAs) post-transcriptionally regulate HK2 by targeting its 3'untranslated region or upstream signaling pathways. While monotherapies often fail due to compensatory pathways and drug resistance, dual-targeting both HK2 and its regulatory miRNAs could achieve substantial metabolic inhibition. This review summarizes recent advances in miRNA-HK2 regulatory networks across cancers and highlights dual-targeting miRNA-HK2 as a promising therapeutic strategy to overcome metabolic plasticity and improve precision, durability, and efficacy in cancer therapy.

MeSH Terms

Humans; Neoplasms; Hexokinase; MicroRNAs; Gene Expression Regulation, Neoplastic; Animals; Signal Transduction; Molecular Targeted Therapy; Glycolysis; Gene Regulatory Networks

같은 제1저자의 인용 많은 논문 (5)